ECM
UBX

ExodusPoint Capital Management’s Unity Biotechnology UBX Stock Holding History

ExodusPoint Capital Management’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-93,597
Closed -$153K – 2270
2023
Q1 		$153K Buy
93,597
+17,697
+23% +$70.9K ﹤0.01% 1601
2022
Q4 		$208K Buy
75,900
+24,911
+49% +$72.4K ﹤0.01% 1450
2022
Q3 		$201K Buy
+50,989
New +$322K ﹤0.01% 1639
2022
Q1 		– Sell
-4,787
Closed -$70K – 2703
2021
Q4 		$70K Buy
4,787
+3,264
+214% +$71.3K ﹤0.01% 2002
2021
Q3 		$46K Sell
1,523
-2,266
-60% -$80K ﹤0.01% 1978
2021
Q2 		$176K Buy
3,789
+1,457
+62% +$70.2K ﹤0.01% 2025
2021
Q1 		$140K Buy
2,332
+295
+14% +$20.1K ﹤0.01% 1934
2020
Q4 		$107K Buy
+2,037
New +$98.2K ﹤0.01% 1826

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return